Navigation Links
Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings
Date:2/12/2010

Amphora Research are please to announce that Maastricht based forensics lab DNalysis have successfully rolled out PatentSafe, protecting their forensic results and allowing their scientists to collate all their data efficently in one secure electronic repository.

Bracknell, UK (PRWEB) Feburary 10, 2010 -- Amphora Research Systems is pleased to announce that DNalysis have implemented PatentSafe to safeguard their forensic results. DNalysis Maastricht is an independent laboratory in the Netherlands that provides comparative DNA analysis for kinship testing and forensic investigation. Being part of The Maastricht Forensic Institute, DNalysis Maastricht interacts with chemists and physicists at DSM, as well as with scientists at the Maastricht University, thereby providing a multidisciplinary approach for evaluation of forensic evidence.

Setting up this first of a kind service they knew that efficient recording, tracking and reporting the findings of their investigations would play an important role in the business. It was also key that what ever system was implemented should be flexible and easy to use.

DNalysis COO Paul van Bilsen said “Starting up an independent company we wanted to get things set up properly from the start. Our analyses can often form part of a legal proceeding, so it was important to us that we could sign the results of the investigations electronically as we go.” Van Bilsen added, “With a large number of samples from different cases passing through our labs it is a real help to be able to search the notebook and pull up everything on a particular sample or case number”.

Jo Worthington, Director of Customer Relations at Amphora said, “Forensic science is another example of a field that can gain clear benefits from electronic working and yet cannot be forced into the rigid structure of electronic notebooks with a chemistry pedigree. We are delighted that PatentSafe's combination of open architecture and legal rigor has fit this niche so well”.

PatentSafe is direct replacement for the bound laboratory notebook. Completely discipline neutral it allows scientists to gain the benefits of electronic working methods without having to experience the upheaval of major changes in working practices. Amphora’s PatentSafe solution delivers significant ROI with little disruption and at a price that can work for organisations of all sizes and types.

Notes for Editors

Launched in 1996, Amphora Research Systems is one of the world's leading suppliers of electronic laboratory notebooks. Its software products, including PatentSafe, are used around the world by large and small companies, including those in the pharmaceutical and chemical sectors. PatentSafe helps scientists to work better, collaborate easily with each other, and protect their inventions.
For further information, please contact: Jo Worthington, Amphora Research Systems
Tel US: +1 800-221-3916×2029
Tel UK: +44 (0) 845 2300160×2029
Email: jow(at)amphora-research(dot)com
http://www.amphora-research.com

DNalysis Maastricht was founded in 2009 and, together with DSM Resolve and the Maastricht University, forms a strategic alliance called The Maastricht Forensic Institute (TMFI). Under the alliance, DNalysis offers a multidisciplinary and personalized approach at forensic DNA investigation and, as such, is unique in The Netherlands. DNalysis conducts research and investigations for the Dutch Public Prosecution Service as well as for private parties. For further information, please see www.tmfi.nl

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3590064.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
5. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
6. Roche to Nominate Independent Directors for Election at Ventanas 2008 Annual Stockholders Meeting
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
8. Kiwa Fertilizers Pass Independent Tests
9. Amarin Appoints Dr. William Mason as Lead Independent Director
10. China Pharma Appoints Three Independent Non-Executive Directors
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):